FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1160-1161 April 12, 2001 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Wolfson, C. PubMed Citation

Dementia, and Alzheimer's disease in particular, is one of the principal causes of disability and decreased quality of life among the elderly and a leading obstacle to successful aging.^1,2 In the next 50 years, the prevalence of Alzheimer's disease in the United States is projected nearly to quadruple — which means that 1 in every 45 Americans will be afflicted with the disease.³ This dramatic increase in prevalence will result primarily from the aging of the population. The percentage of Americans older than 75 years of age is predicted to increase from approximately 5.9 percent in 2000 to 11.4 percent . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Williamson, J. D., Espeland, M., Kritchevsky, S. B., Newman, A. B., King, A. C., Pahor, M., Guralnik, J. M., Pruitt, L. A., Miller, M. E., for the LIFE Study Investigators, (2009). Changes in Cognitive Function in a Randomized Trial of Physical Activity: Results of the Lifestyle Interventions and Independence for Elders Pilot Study. J Gerontol A Biol Sci Med Sci 64A: 688-694 [Abstract] [Full Text]  
• DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., Kronmal, R. A., Ives, D. G., Saxton, J. A., Lopez, O. L., Burke, G., Carlson, M. C., Fried, L. P., Kuller, L. H., Robbins, J. A., Tracy, R. P., Woolard, N. F., Dunn, L., Snitz, B. E., Nahin, R. L., Furberg, C. D., for the Ginkgo Evaluation of Memory (GEM) Study In, (2008). Ginkgo biloba for Prevention of Dementia: A Randomized Controlled Trial. JAMA 300: 2253-2262 [Abstract] [Full Text]  
• Theppeang, K., Glass, T. A., Bandeen-Roche, K., Todd, A. C., Rohde, C. A., Schwartz, B. S. (2008). Gender and Race/Ethnicity Differences in Lead Dose Biomarkers. AJPH 98: 1248-1255 [Abstract] [Full Text]  
• Deininger, M. H., Fimmen, B. A., Thal, D. R., Schluesener, H. J., Meyermann, R. (2002). Aberrant Neuronal and Paracellular Deposition of Endostatin in Brains of Patients with Alzheimer's Disease. J. Neurosci. 22: 10621-10626 [Abstract] [Full Text]  
• Brookmeyer, R., Corrada, M. M., Curriero, F. C., Kawas, C. (2002). Survival Following a Diagnosis of Alzheimer Disease. Arch Neurol 59: 1764-1767 [Abstract] [Full Text]